iXgene
Biotechnology Research • 
Shinjuku-Ku, Tokyo, Japan • 1-10 Employees
Company overview
| Headquarters | Shinjuku-Ku, Tokyo, Japan |
| Website | |
| NAICS | 541714 |
| Founded | 2020 |
| Employees | 1-10 |
| Socials |
Key Contact at iXgene
Atsushi Mizuno
Representative Director
iXgene Email Formats
iXgene uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@ixgene.inc), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@ixgene.inc | 100% |
About iXgene
iXgene Inc. a biotech company based in Tokyo, is developing next-generation cell therapies based on genome-edited iPS cells. Our flagship product targets glioblastoma, one of the most challenging cancers, but our vision extends far beyond, aiming to apply this technology to various other diseases. We are building a platform that can deliver precise, scalable, and effective treatments across multiple therapeutic areas.
iXgene revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
iXgene has never raised funding before.
iXgene Tech Stack
Discover the technologies and tools that power iXgene's digital infrastructure, from frameworks to analytics platforms.
Font scripts
Security
Tag managers
Reverse proxies
Form builders
Programming languages
Miscellaneous
Hosting
Analytics
Blogs
JavaScript libraries
Analytics
Germany
South Africa
Australia
United States
United Kingdom
Frequently asked questions
4.8
40,000 users
